Peer-reviewed veterinary case report
Efficacy of benzoxazinorifamycins in a mouse model of Chlamydia pneumoniae lung infection.
- Journal:
- Antimicrobial agents and chemotherapy
- Year:
- 2008
- Authors:
- Campbell, Lee Ann et al.
- Affiliation:
- Department of Pathobiology · United States
Abstract
The efficacy of rifalazil and other benzoxazinorifamycins was tested in a mouse model of lung infection against Chlamydia pneumoniae. Rifalazil and six related new chemical entities all showed efficacy after one dose per day for 3 days at either 3 or 1 mg/kg of body weight.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/18332169/